Drug Accelerator Model Lures New Investors to Biomotiv
By Marie Powers
Thursday, August 8, 2013
Drug development accelerator Biomotiv LLC added $25 million to boost its capital commitment to $46 million, with Nationwide Mutual Insurance Co. and several individual investors joining founding investors University Hospitals of Cleveland and the Harrington Family. Nationwide, based in Cleveland, will appoint a representative to the company's board of managers.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.